Wall Street Analysts See ResMed (RMD) as a Buy: Should You Invest?
Yahoo Finance · 13 hours ago
Open | 218.26 |
High | 219.60 |
Low | 216.66 |
Mkt Cap | 32.13B |
P/E (TTM) | 33.69 |
Div & Yield | 1.92 & 0.88% |
Prev. Close | 218.74 |
52 Wk. Low | 132.24 |
52 Wk. High | 229.97 |
Related stocks
Manufacturer of CPAP masks, machines and products that diagnose, treat or help manage respiratory conditions
ResMed Inc. is an American medical equipment company based in San Diego, California. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 1.2B | 7.20% ▲ |
Net Income | 300.49M | 29.20% ▲ |
Diluted EPS | 2.13 | 29.10% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.06 | - |
Q1 2024 | $1.91 | $2.13 |
Q4 2023 | $1.80 | $1.88 |
S&P FuturesES=F | 5,346.75+1.50 (+0.03%) |
Dow FuturesYM=F | 40,016.00+10.00 (+0.02%) |
Nasdaq FuturesNQ=F | 18,813.25+14.00 (+0.07%) |
Tesla, Inc.TSLA | 186.60+6.66% |
953.86+0.64% | |
MGO Global, Inc.MGOL | 1.2500+446.57% |